FDA Inspection 1112255 — Pfizer Ireland Pharmaceuticals Unlimited Company

Pfizer Ireland Pharmaceuticals Unlimited Company — FEI 3004145594

The FDA completed an inspection of Pfizer Ireland Pharmaceuticals Unlimited Company on November 9, 2018 in Dublin 22. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 9, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dublin 22 (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)